Reference : ABVD (8 cycles) vs. BEACOPP (4 escalated cycles => 4 baseline) in stage III - IV low ...
Scientific congresses and symposiums : Paper published in a journal
Human health sciences : Hematology
http://hdl.handle.net/2268/167474
ABVD (8 cycles) vs. BEACOPP (4 escalated cycles => 4 baseline) in stage III - IV low risk Hodgkin Lymphoma (IPS 0-2): final results of LYSA H34 trial
English
André, M. []
DE PRIJCK, Bernard mailto [Centre Hospitalier Universitaire de Liège - CHU > > Hématologie clinique >]
Kentos, A. []
Van Hoof, A. []
Bonnet, Christophe mailto [Université de Liège - ULiège > > GIGA-R : Hématologie >]
Sonet, A. []
Maerevoet, M. []
Van Den Neste, E. []
Bosly, A. []
Mounier, N. []
2014
Belgian Journal of Hematology
Ariez Medical Publishing
12
Yes
International
Amsterdam
The Netherlands
29th General Annual Meeting of the Belgian Hematological Society
du 30 janvier 2014 au 1er février 2014
Gent
http://hdl.handle.net/2268/167474

File(s) associated to this reference

Fulltext file(s):

FileCommentaryVersionSizeAccess
Open access
BHS - 2014 - ABVD (8 cycles) vs BEACOPP....pdfPublisher postprint85.35 kBView/Open

Bookmark and Share SFX Query

All documents in ORBi are protected by a user license.